Serial Number | 98303869 |
Word Mark | VILLAR BIOTECH |
Filing Date | Thursday, December 7, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, October 23, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the literal elements "VILLAR BIOTECH" in a stylized font to the right of a diamond shape. |
Goods and Services | Dietary supplements |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, December 7, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Saturday, January 12, 2019 |
First Use In Commerce Date | Saturday, January 12, 2019 |
Party Name | BIOLOGICAL SUPPLEMENTS LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Los Angeles, CA 90048 |
Event Date | Event Description |
Thursday, December 7, 2023 | NEW APPLICATION ENTERED |
Thursday, March 7, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, March 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, July 8, 2024 | NON-FINAL ACTION E-MAILED |
Monday, July 8, 2024 | ASSIGNED TO EXAMINER |
Monday, July 8, 2024 | NON-FINAL ACTION WRITTEN |
Monday, July 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, October 23, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, October 23, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |